Pioneering the AI Frontier of Ovarian Cancer Detection
Miniaturized In Vivo Cell Collection — Reaching the Fallopian Tube to Capture Disease at Its Source
FemDx is an AI-powered women’s health platform pioneering ultra-miniature endoscopic technology for earlier detection of ovarian cancer and other gynecologic diseases, and a proud member of NVIDIA Inception.
AI-Powered Precision.
Unprecedented Access to the Source.
FemDx is building a new frontier in women’s health AI by capturing previously difficult-to-access raw cellular and imaging data directly from inside the fallopian tube—a critical site in the development of many ovarian cancers. This unique, high-value dataset provides the foundation for our AI platform to learn from disease at its source, with the potential to enable earlier and more precise detection of ovarian cancer and other gynecologic diseases.
Detecting Ovarian Cancer at Its Origin
FemDx is advancing a novel approach to ovarian cancer detection through in vivo collection of fallopian tube epithelial cells, followed by cytopathologic evaluation and AI-powered cellular analysis to identify cancerous and precancerous changes directly at the site where many ovarian cancers originate.
The Smallest Endoscope Ever Cleared by the FDA
FemDx is an AI-powered women’s health platform pioneering ultra-miniature endoscopic technology for earlier detection of ovarian cancer and other gynecologic diseases. FemDx has developed the world’s smallest FDA-cleared endoscope, enabling unprecedented access to the fallopian tubes.